Preferences, Patient [qlco]
Chemoprevention [topp]
Esophageal Adenocarcinoma [neop]
Barrett Esophagus [dsyn]
objectives [inpr]
Evidence [ftcn]
Suggest [idcn]
Aspirin [orch, phsu]
celecoxib [orch, phsu]
Risk [qlco]
Esophageal Adenocarcinoma [neop]
Patients [podg]
Barrett Esophagus [dsyn]
Drugs [phsu]
side effects [ftcn]
Aim [idcn]
To [qlco]
Preferences [idcn]
Two [qnco]
Drugs [phsu]
Patients [podg]
Methods [inpr]
Preferences [idcn]
Data [idcn]
Collected [idcn]
Patients [podg]
Using [ftcn]
Customized [acty]
Questionnaire [inpr]
Standard [qlco]
Risk [qlco]
Communication [socb]
techniques [inpr]
summary [inpr]
Profile [lbpr]
Benefits [qnco]
celecoxib [orch, phsu]
Aspirin [orch, phsu]
Presented [idcn]
Drugs [phsu]
Reducing [qlco]
Risk [qlco]
Esophageal Adenocarcinoma [neop]
Increasing [ftcn]
Risk [qlco]
GI [idcn]
Events [evnt]
celecoxib [orch, phsu]
Increased [qnco]
Risk [qlco]
Myocardial Infarction [dsyn]
Aspirin [orch, phsu]
Reduced [qlco]
Risk [qlco]
Factor [ftcn]
Drug [phsu]
Analyzed [resa]
Result [ftcn]
One [qnco]
Subject [grup]
COMPLETED [qlco]
Study [mnob]
base [inch]
Case [ftcn]
condition [dsyn]
stated [geoa]
Take [hlca]
celecoxib [orch, phsu]
Aspirin [orch, phsu]
P NOS [aapp, imft]
Patients [podg]
Identified [qlco]
Risk [qlco]
Myocardial Infarction [dsyn]
Primary Reason [idcn]
Unwilling [menp]
Take [hlca]
celecoxib [orch, phsu]
Low Risk [fndg]
Esophageal Adenocarcinoma [neop]
Aspirin [orch, phsu]
scenarios [ftcn]
Benefits [qnco]
celecoxib [orch, phsu]
Improved [qlco]
Reduced [qlco]
majority [socb]
Continued [idcn]
To [qlco]
Find [fndg]
Unacceptable [qlco]
Conclusions [idcn]
majority [socb]
Survey [inpr]
stated [geoa]
Take [hlca]
Aspirin [orch, phsu]
Not [ftcn]
Take [hlca]
celecoxib [orch, phsu]
Patients [podg]
Interested [menp]
Esophageal Adenocarcinoma [neop]
Chemoprevention [topp]
Amount [qnco]
Protection [fndg]
Side Effect [patf]
Profile [lbpr]
Drug [phsu]
acceptability [qlco]
Data [idcn]
Inform [aapp, imft, phsu]
Physicians [prog]
Patients [podg]
Willing [fndg]
To [qlco]
Chemoprevention [topp]
